Novacyt S.A. (CDI) (NCYT) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 May 2022 12:21 PM
RNS
Liquidity Agreement Update and Total Voting Rights
28 Apr 2022 07:00 AM
RNS
Full year results and update on growth strategy
26 Apr 2022 07:00 AM
RNS
DHSC dispute update
20 Apr 2022 07:00 AM
RNS
Notice of Results and Investor Presentation
12 Apr 2022 07:00 AM
RNS
Approval of COVID-19 test under CTDA legislation
01 Apr 2022 11:45 AM
RNS
Liquidity Agreement Update and Total Voting Rights
25 Mar 2022 05:25 PM
RNS
Director/PDMR Shareholding
18 Mar 2022 06:00 PM
RNS
Director/PCA Dealing
15 Mar 2022 02:30 PM
RNS
Director/PDMR Shareholding
11 Mar 2022 08:00 AM
RNS
Holdings in Company
01 Mar 2022 01:00 PM
RNS
Liquidity Agreement Update and Total Voting Rights
18 Feb 2022 04:05 PM
RNS
Holdings in Company
17 Feb 2022 07:00 AM
RNS
Approval of COVID-19 test under CTDA legislation
15 Feb 2022 04:00 PM
RNS
Holdings in Company
04 Feb 2022 07:00 AM
RNS
Long Term Incentive Plan
01 Feb 2022 02:30 PM
RNS
Liquidity Agreement and Total Voting Rights
25 Jan 2022 07:00 AM
RNS
Strategy and Full Year 2021 Trading Update
04 Jan 2022 04:30 PM
RNS
Liquidity Agreement and Total Voting Rights
01 Dec 2021 02:30 PM
RNS
Total Voting Rights
26 Nov 2021 07:00 AM
RNS
Approval of COVID-19 test under CTDA legislation
02 Nov 2021 07:00 AM
RNS
Validation of COVID-19 tests in the UK under CTDA
01 Nov 2021 05:30 PM
RNS
Liquidity Agreement and Total Voting Rights
19 Oct 2021 04:15 PM
RNS
Results of annual general meeting
01 Oct 2021 02:30 PM
RNS
Total Voting Rights
30 Sep 2021 07:00 AM
RNS
R&D update
29 Sep 2021 05:00 PM
RNS
Notice of AGM
29 Sep 2021 07:00 AM
RNS
Notice of rescheduled AGM
27 Sep 2021 07:00 AM
RNS
Half year 2021 results
16 Sep 2021 07:00 AM
RNS
Proposed accounting treatment of DHSC dispute
13 Sep 2021 07:00 AM
RNS
AGM voting
01 Sep 2021 11:30 AM
RNS
Liquidity Agreement and Total Voting Rights
20 Aug 2021 07:00 AM
RNS
Notice of AGM
18 Aug 2021 07:00 AM
RNS
Half Year Update
05 Aug 2021 07:00 AM
RNS
Notice of investor meeting
02 Aug 2021 01:30 PM
RNS
Total Voting Rights
29 Jul 2021 07:00 AM
RNS
David Allmond to be CEO, Graham Mullis to retire
06 Jul 2021 02:40 PM
RNS
Director/PDMR Shareholding
01 Jul 2021 02:30 PM
RNS
Liquidity Agreement and Total Voting Rights
29 Jun 2021 07:00 AM
RNS
Publication of Annual Report
29 Jun 2021 07:00 AM
RNS
Expansion of PathFlow COVID-19 LFT portfolio
22 Jun 2021 07:00 AM
RNS
Full year 2020 results and update on strategy
18 Jun 2021 07:00 AM
RNS
Update on Notice of 2020 Full Year Results
03 Jun 2021 07:00 AM
RNS
Launch of two new PCR COVID-19 assays
01 Jun 2021 02:00 PM
RNS
Liquidity Agreement and Total Voting Rights
26 May 2021 07:00 AM
RNS
Launch of VersaLab Portable
21 May 2021 07:00 AM
RNS
DHSC Dispute Update
17 May 2021 07:00 AM
RNS
Inclusion of SNPsig in the NHS England Framework
04 May 2021 01:00 PM
RNS
Total Voting Rights
04 May 2021 07:00 AM
RNS
Novacyt donates 1 million COVID-19 tests to UNICEF
23 Apr 2021 07:00 AM
RNS
R&D and UK operational update

Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying an extensive range assays and reagents worldwide.

Novacyt launched on LSE in 2017 under the ticker NCYT. 

Novacyt share price launched at 61p. 

UK 100

Latest directors dealings